Agran Libbie’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$223K Sell
2,996
-75
-2% -$5.58K 0.05% 116
2016
Q4
$224K Sell
3,071
-50
-2% -$3.62K 0.05% 115
2016
Q3
$246K Buy
3,121
+200
+7% +$16.3K 0.07% 101
2016
Q2
$241K Hold
2,921
– – 0.06% 118
2016
Q1
$212K Buy
+2,921
New +$222K 0.05% 118
2015
Q4
– Sell
-2,249
Closed -$207K – 121
2015
Q3
$207K Hold
2,249
– – 0.06% 115
2015
Q2
$221K Buy
2,249
+24
+1% +$2.46K 0.06% 115
2015
Q1
$219K Hold
2,225
– – 0.05% 129
2014
Q4
$206K Hold
2,225
– – 0.05% 125
2014
Q3
$209K Buy
+2,225
New +$201K 0.05% 121

Other funds holding NVS

Agran Libbie's NVS Position: Q1 2017 in Review

Agran Libbie reduced its Novartis (NVS) stake by 2.4% in Q1 2017, selling an estimated $5.58K and leaving 2,996 shares worth $223K. The position accounts for 0.05% of the portfolio, ranked #116.

Agran Libbie first reported a position in NVS in Q3 2014 and has held it in 10 quarters since. The position peaked at $246K in Q3 2016. 909 funds tracked by Wall St. Rank hold NVS as of Q1 2017.

  • Agran Libbie held 2,996 shares of Novartis worth $223K as of Q1 2017.
  • Agran Libbie sold 75 Novartis shares in Q1 2017, an estimated $5.58K.
  • Novartis made up 0.05% of Agran Libbie's portfolio in Q1 2017, its #116 holding.
  • Agran Libbie first reported a position in Novartis in Q3 2014 and has held it in 10 quarters since.
  • Agran Libbie's Novartis position peaked at $246K in Q3 2016.
  • 909 funds tracked by Wall St. Rank held Novartis as of Q1 2017.

Based on Agran Libbie's 13F filing for Q1 2017, filed 27 Apr 2017.